Switzerland · What does Forty51 Ventures invest in?
Forty51 Ventures invests most often at Series A (100% of the rounds on record), in sectors such as Drugs, Metabolites and Life Science.
Forty51 Ventures highlights
- 01
1 rounds on record
- 02
Mostly Series A: 100% of its rounds
What they do
FORTY51 Ventures is a biotech venture creator company building we invest in European early stage biotech opportunitiesFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries A
- Sectors
- DrugsMetabolitesLife Science
- Based in
- Basel, Switzerland
- Cold pitches
- Accepted
The record
Every round we can evidence, newest first1 appearances
- 2025
1 round
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
FGFrancesco Giuseppe CavalliniExecutive OfficeriFiling they signed
RZRiccardo ZorzettoExecutive OfficeriFiling they signed
We also hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
1 of 4 we have independently watched raise
Mosanna-therapeuticsEdoebEdpbIco
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.